Download file, English (1 MB PDF) - RHO
Download file, English (1 MB PDF) - RHO
Download file, English (1 MB PDF) - RHO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Uganda<br />
Priorities • Training at various levels: TOT, pre-service, in-service.<br />
• Establish good practice environment (a room, privacy, a good light, basic<br />
equipment needed).<br />
• Resource commitment/mobilization from the various stakeholders.<br />
• Continued advocacy.<br />
Activities<br />
SHORT TERM<br />
• Advocacy for cervical cancer screening in all social groups; prevention, palliative<br />
care.<br />
• Prevention services. Identify partners to support this.<br />
• Relevant interaction with politicians.<br />
MEDIUM TERM<br />
• Target pre-service training to change scope.<br />
• Strengthen in-service training.<br />
• Country team to lobby for package to scale up screening (so that when women<br />
bring children for immunization, they are screened).<br />
• Continued advocacy and lobbying companies to implement a corporate<br />
responsibility policy to support regular breast examination and screening for<br />
cancer of the cervix for employees.<br />
LONG TERM<br />
• Comprehensive approach (primary and secondary prevention).<br />
• Scale up programs.<br />
• Address issues of equity.<br />
• Advocate for policy change, e.g., where to assign gynaecologists, to certain<br />
districts.<br />
• Get support of past and new parliamentarians.<br />
• Establish dialogue within the region to lobby as a common market for the HPV<br />
vaccine, which can help obtain it at a reduced price.<br />
Technical support • Technical support to ramp up passion in MOH leadership. (How do we do it? Who<br />
can do it?).<br />
• Assistance to help coordinate various areas, stakeholders (to leverage funds).<br />
• Meet: MOH team—three participants (from this conference).<br />
• Work with leaders HIV/AIDS program.<br />
Report of an African Regional Meeting on Cervical Cancer: September 2010 90